Group 1 - FTSE Russell announced quarterly review changes for multiple indices, effective after the market close on September 19, 2025 [1][3] - The FTSE China A50 Index will include companies such as BeiGene, Eoptolink Technology, WuXi AppTec, and Zhongji Innolight, which are primarily from the pharmaceutical and AI computing sectors [1][5] - The newly included stocks have shown significant price increases, with BeiGene achieving a 102.51% increase in market value, and other stocks in the AI computing sector seeing gains of over 200% and 300% [5][6] Group 2 - The FTSE China A50 Index is composed of the 50 largest stocks listed on the Shanghai and Shenzhen exchanges, reviewed quarterly [5] - The index adjustments reflect the strong performance of the pharmaceutical and AI computing sectors, which are considered the main drivers of the A-share market this year [7][8] - Analysts suggest that the demand for computing power in the AI industry is expected to grow explosively, benefiting the entire computing power supply chain [7][8]
A50重大调整，这几只“翻倍股”被纳入
Zheng Quan Shi Bao·2025-09-03 13:42